Similar articles

• Churg-Strauss syndrome with peripheral polyneuropathy refractory to steroideal and immunosuppressive therapy successfully treated with plasma exchange.

  Fregoni V, Perseghin P, Epis R, De Fazio P, Nalli G. Fregoni V, et al. Recenti Prog Med. 1995 Sep;86(9):353-4. Recenti Prog Med. 1995. PMID: 7569297 No abstract available.
• [Churg-Strauss syndrome and antineutrophil cytoplasmic antibodies].

  Lafont A, Olivé A, Abad E, Coll-Cantí J. Lafont A, et al. Med Clin (Barc). 1997 May 24;108(20):797. Med Clin (Barc). 1997. PMID: 9265086 Spanish. No abstract available.
• L6. Eosinophilic granulomatosis with polyangiitis: future therapies.

  Moosig F. Moosig F. Presse Med. 2013 Apr;42(4 Pt 2):510-2. doi: 10.1016/j.lpm.2013.01.006. Epub 2013 Feb 28. Presse Med. 2013. PMID: 23453508 Review. No abstract available.
• Treatment for Churg-Strauss syndrome: induction of remission and efficacy of intravenous immunoglobulin therapy.

  Taniguchi M, Tsurikisawa N, Higashi N, Saito H, Mita H, Mori A, Sakakibara H, Akiyama K. Taniguchi M, et al. Allergol Int. 2007 Jun;56(2):97-103. doi: 10.2332/allergolint.R-07-142. Epub 2007 May 1. Allergol Int. 2007. PMID: 17460439 Review.
• B cell depletion therapy and eosinophilic granulomatosis with polyangiitis with hepatic involvement.

  Grigoriou A, Endean A, Sangle SR, D'Cruz DP. Grigoriou A, et al. Rheumatology (Oxford). 2014 Oct;53(10):1741. doi: 10.1093/rheumatology/keu290. Epub 2014 Aug 4. Rheumatology (Oxford). 2014. PMID: 25096603 No abstract available.